We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This publication provides guidance on routine quality control tests for tomosynthesis systems carried out by medical physics services.
Information for women whose antenatal screening test detects syphilis.
Information for parents and carers who are offered screening for severe combined immunodeficiency (SCID) for their babies.
This information is for parents whose baby may have Patau’s syndrome. It can help them talk through the next stages of their care with health professionals.
This document provides general information relating to screening pathway requirements publications for all current population screening programmes in England.
These documents support screening quality assurance (QA), and screening providers carrying out annual 'Right Results' audits in breast screening.
This guidance outlines the scope and standards for medical physics services for the NHS breast screening programme.
The NHS breast screening programme's specification for mobile breast screening units (MBSUs), also called mobile digital trailers.
These documents set out how the failsafe processes work for the NHS diabetic eye screening (DES) programme.
This document sets out an overview of the operational pathways in the NHS Diabetic Eye Screening (DES) programme.
Information about the screening test that takes place between 18 weeks and 20 weeks 6 days of pregnancy, commonly known as the 20-week screening scan.
Healthcare professionals can use this leaflet to answer parents' common questions on a babies' hearing loss in one ear.
An overview of the sickle cell and thalassaemia (SCT) screening end-to-end pathway.
Advice for prescribers on the risk of misuse of pregabalin and gabapentin, and suggestions for a balanced and rational use of these medicines.
An overview of the newborn and infant physical examination screening end-to-end pathway.
Information and advice for parents of babies with suspected medium-chain acyl-CoA dehydrogenase deficiency (MCADD) following a baby’s screening test result.
A collection of resources for our NHS Bowel Cancer Screening for patients with Lynch Syndrome.
Information for parents of babies with possible maple syrup urine disease (MSUD) following a baby’s screening test result.
An overview of the abdominal aortic aneurysm (AAA) screening end-to-end pathway.
Information for local providers and commissioners on leading NHS breast screening services.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).